Gene Therapy in Parkinson Disease: From Preclinical Studies in Primates to a Phase I Clinical Trial

被引：0
|
作者：
Jarraya, B. [1 ,3 ]
Lepetit, H. [3 ]
Ralph, S. [2 ]
Miskin, J. [2 ]
Gurruchaga, J-M [3 ]
Fenelon, G. [3 ]
Boulet, S. [1 ]
Jan, C. [1 ]
Bonvento, G. [1 ]
Azzouz, M. [5 ]
Brugiere, P. [3 ]
Kingsman, S. [2 ]
Naylor, S. [2 ]
Hantraye, P. [1 ]
Remy, P. [1 ,3 ]
Mazarakis, N. D. [4 ]
Mitrophanous, K. [2 ]
Palfi, S. [1 ,3 ]
机构：
[1] CEA CNRS MirCen, Fontenay Aux Roses, France
[2] Oxford BioMed UK Ltd, Oxford, England
[3] Univ Paris, Hop Henri Mondor, Paris, France
[4] Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Gene Therapy, London SW7 2AZ, England
[5] Univ Sheffield, Sch Med, Neurol Unit, Sheffield S10 2TN, S Yorkshire, England
来源：
HUMAN GENE THERAPY | 2010年 / 21卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：764 / 765
页数：2
相关论文
共 50 条
  • [31] A Phase I Clinical Trial of Osteoarthritis Gene Therapy (NCT02790723)
    Sellon, Jacob
    Smith, Jay
    De la Vega, Rodolfo
    Wisniewski, Stephen
    Jurisson, Mary
    Scrabeck, Tyson
    Block, Julie
    Mills, Candee
    Coenen, Michael
    Hawse, Gresin
    Abdul, Temilola
    Keravala, Annahita
    Chalberg, Thomas
    Robbins, Paul
    Ghivizzani, Steven
    Evans, Christopher H.
    MOLECULAR THERAPY, 2022, 30 (04) : 376 - 376
  • [32] A phase I/II clinical trial of β-globin gene therapy for β-thalassemia.
    Bank, A
    Dorazio, R
    Leboulch, P
    COOLEY'S ANEMIA EIGHTH SYMPOSIUM, 2005, 1054 : 308 - 316
  • [33] Prosavin®, a dopamine gene therapy for advanced Parkinson's disease: 5 years phase I/II clinical update
    Palfi, S.
    Gurruchaga, J. M.
    Watts, C.
    Buttery, P. C.
    Lepetit, H.
    Fenelon, G.
    Binley, K.
    Howard, K.
    Lad, Y.
    Tuckwell, N. J.
    Hantraye, P.
    Barker, R. A.
    Mitrophanous, K. A.
    HUMAN GENE THERAPY, 2018, 29 (12) : A87 - A87
  • [34] Improvements in Clinical and Radiographic Outcomes in a Phase I Study of AAV-GAD Gene Therapy for Parkinson's Disease
    Kaplitt, Michael G.
    Eidelberg, David
    Feigin, Andrew
    Fitzimmons, Helen
    Lawlor, Patricia
    Strybing, Kristin
    Cox, Marie
    Tang, Chris
    Bland, Ross
    During, Matthew J.
    MOLECULAR THERAPY, 2006, 13 : S280 - S281
  • [35] Are clinical tools able to diagnose Parkinson's disease at the 'preclinical phase'?
    Deste, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 336 - 337
  • [36] Osteoarthritis Gene Therapy: Interim Report from a Phase I Clinical Trial (NCT02790723)
    Evans, Christopher
    MOLECULAR THERAPY, 2021, 29 (04) : 289 - 289
  • [37] Development of gene therapy for pancreatic carcinoma: from experimental models to phase I clinical trial.
    Buscail, Louis
    Bournet, Barbara
    Vernejoul, Fabienne
    Lulka, Hubert
    Cambois, Gilles
    Hanoun, Naima
    Gross, Fabian
    Tiraby, Jean
    Cordelier, Pierre
    CANCER RESEARCH, 2013, 73 (08)
  • [38] Gene delivery of neurturin (Cere-120) for Parkinson's disease: Studies in nonhuman primates and clinical trials
    Kordower, J. H.
    Herzog, C. D.
    Gasmi, M.
    Bartus, R. T.
    CELL TRANSPLANTATION, 2008, 17 (04) : 469 - 469
  • [39] Gene therapy for HIV-infection:: Preclinical and clinical studies
    Kimpe, Janine
    van Lunzen, Jan
    Glaunsinger, Tobias
    Stahmer, Ingrid
    Baum, Christopher
    Kuehlcke, Klaus
    Naundorf, Sonja
    Martinius, Holger
    Hermann, Felix
    Newrzela, Sebastian
    Mueller, Ingrid
    Brauer, Francis
    Alexandrov, Alexander
    von Laer, Dorothee
    BLOOD CELLS MOLECULES AND DISEASES, 2008, 40 (02) : 290 - 290
  • [40] DAVANAT® and colon cancer:: Preclinical and clinical (phase I) studies
    Klyosov, Anatole A.
    Zomer, Eliezer
    Platt, David
    CARBOHYDRATE DRUG DESIGN, 2006, 932 : 67 - 104
12345